The Lymphedema Treatment Act Passes the House

Home Blog The Lymphedema Treatment Act Passes the House

On December 12, the Lymphedema Treatment Act was passed the House of Representatives with a vote of 230 to 192. The LTA bill was recently rolled into H.R. 3, the Lower Drug Costs Now Act of 2019. H.R. 3 provides the authority, mandate and tools for the Secretary of Health and Human Services to negotiate to lower the price of drugs and caps annual out-of-pocket costs in Medicare Part D. The language for the Lymphedema Treatment Act is included by expanding the coverage of treatment supplies for Medicare beneficiaries suffering from lymphedema. The full House announcement about H.R. 3 can be read here.  

Passing the House is a giant milestone for this legislation. However, the work is not done.  

H.R. 3 as passed by the House is not expected to be taken up in the Senate as there is no direct Senate companion bill. There may be a compromise drug pricing bill that combines provisions from both chambers. The Senate may choose to put the LTA into another Senate package. All options are currently on the table. 

Please continue to reach out to your Senators to let them know what the Lymphedema Treatment Act means to you. Click here to find your representative and ask them for their support for S. 518! 


Back to Top